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Background:  Grey matter and other structural brain abnormalities are consistently reported in 
first-onset schizophrenia, but less is known about the extent of neuroanatomical changes in first-
onset affective psychosis. 
Aims: To determine which brain abnormalities are specific to (a) schizophrenia and (b) affective 
psychosis. 
Method: We obtained dual-echo (proton density/T2-weighted) MR images and carried out 
voxel-based analysis on the images of 73 first-episode psychosis patients (schizophrenia=44, 
affective psychosis=29) and 58 healthy controls.  
Results: Both patients with schizophrenia and patients with affective psychosis had enlarged 
lateral and third ventricle volumes. Regional cortical grey matter reductions (including bilateral 
anterior cingulate gyrus, left insula and left fusiform gyrus) were evident in affective psychosis 
but not in schizophrenia, although patients with schizophrenia displayed decreased hippocampal 
grey matter and increased striatal grey matter at a more liberal statistical threshold. 
Conclusions: Both schizophrenia and affective psychosis are associated with volumetric 
abnormalities at the onset of frank psychosis, with some of these evident in common brain areas.  





Neuroimaging studies of first-episode schizophrenia have shown neuroanatomical abnormalities, 
including ventricular enlargement (Cahn et al, 2002) and subtle grey matter deficits in the whole 
brain (Fannon et al, 2000a), frontal and temporal lobes (Job et al, 2002). Furthermore, some 
abnormalities such as basal ganglia enlargement seem to appear early in the illness but only 
following antipsychotic exposure (Lawrie et al, 1998).  While abnormalities in the cingulate 
gyrus (Sassi et al, 2004) and temporal lobe (Kasai et al, 2003a) have been observed in first-onset 
affective psychosis, it is not clear whether they are as frequent and severe as in schizophrenia.    
Using high resolution MRI and voxel-based morphometry (VBM) methods of image analysis, 
we set out to examine the brain structure of patients participating in an epidemiological study of 
first-episode psychosis.   We predicted that compared to healthy controls, patients with 
schizophrenia and affective psychosis would have frontal and temporal lobe grey matter deficits 







Subjects were inner city South London residents enrolled in an epidemiological study of first-
onset psychosis (ÆSOP: Aetiology and Ethnicity in Schizophrenia and Other Psychoses).  
Details of the AESOP study and the overall methodology can be found in Morgan et al, (2006).  
Inclusion criteria for the MRI study were: (a) age 16-65; (b) resident in defined area (population 
265,950); (c) presenting consecutively for the first time to local psychiatric services (in-patient and 
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out-patient) between 1997-2000 with symptoms meeting functional psychosis criteria (ICD10: F20 
[Schizophrenia] and F30-39 [Affective disorders - psychotic codings]) (WHO, 1992).   Exclusion 
criteria were: (a) head trauma history with > one hour unconsciousness; (b) central nervous system 
disease; (c) poor English fluency; (d) transient psychotic symptoms resulting from acute 
intoxication (ICD-10), following consumption of psychoactive substance.     
 
Only patients meeting criteria for a narrow definition of schizophrenia (ICD-10 F20) were 
included in the ‘Schizophrenia’ group. Patients diagnosed with bipolar disorder or depressive 
psychosis were allocated to the ‘Affective Psychosis’ group (ICD-10 F30-39).  To ensure the 
diagnostic homogeneity of the two groups, patients with schizoaffective disorder were excluded 
from either group.   
 
153 patients diagnosed with either schizophrenia or affective psychosis were enrolled in the 
ÆSOP study. 97 of those patients consented to MRI scanning.  Nine of these patients did not 
complete the full scanning procedure and therefore were not included in the analysis. 15 further 
scans were excluded due to:  a) subject motion=13; b) congenital hydrocephalus=1; c) sub-
arachnoid cyst=1.    Therefore, 73 patients were included in the analysis.  44 of these patients 
were diagnosed with schizophrenia; 12 with psychotic depression and 17 with bipolar disorder.  
These 73 patients were younger (mean age 27.1 [sd 7.6] years versus 30.1 [sd 9.1] years, t=2.8, 
p=0.007) and comprised proportionately more white British patients (27 [37%] versus 12[16%], 
χ2=8.4, p=.004) than the 80 patients not included in the MRI analysis.  There were no significant 
differences between the patients included and those not included in the analysis in terms of the 
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proportion of male patients (χ2=1.2, p=0.27) and the number of patients with schizophrenia 
(χ2=2.3, p=0.13).  
 
Controls 
58 controls were recruited from the same community as the patients.      Exclusion criteria were 
the same as those for the patients’.  Evidence of past or present psychosis, screened with the 
Psychosis Screening Questionnaire (Bebbington and Nayani, 1995), was an additional exclusion 
criterion. We excluded eight MRI scans (subject motion=7; suspected hydrocephalus=1).   For 
the MRI analysis, controls were separately compared to the patients with a) schizophrenia and b) 
affective psychosis.  The controls were paired with the patients in the schizophrenia and affective 
psychosis groups on the basis of age (+/- 5 years) and sex.  Thus, 44 paired controls were 
included the analysis of the schizophrenia patients and 29 paired controls in the analysis of the 
patients with affective psychosis (Table 1).   In addition to the patient versus control subject 
analyses, an analysis directly comparing patients with schizophrenia to those with affective 
psychosis was conducted.  
 
Ethical approval was granted by the South London and Maudsley Trust Research Ethical 
Committee.  All participants gave written, informed consent. 
 
Clinical assessments 
Patients were interviewed using the WHO Schedules for Clinical Assessment in Neuropsychiatry 
(WHO-SCAN) (WHO, 1994). We made ICD-10 diagnoses in consensus meetings with senior 
clinicians (RM or JL), using WHO-SCAN information and clinical notes.   Using the WHO-
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SCAN data, we encoded (in weeks): duration of illness (DOI) as the onset date of psychotic 
symptoms to MRI date; and lifetime duration of antipsychotic exposure (DAE) (to MRI date).    
Total symptomology was scored by summing the WHO-SCAN’s individual item scores using 
the algorithm of Wing and Sturt (1978).  
 
Structural MR Image acquisition 
Scans were acquired with a GE Signa 1.5-T system, at the Maudsley Hospital, London. 
Contiguous, interleaved proton-density- and T2-weighted 3mm thick coronal plane dual-echo 
images were acquired, providing whole brain coverage. A repetition time of 4000ms and 
effective echo times of 20ms and 85ms were used with 8-echo train length. Matrix size was 256 
x 192, collected from a rectangular field-of-view of 22cm x 16.5cm, giving an in-plane 
resolution of 0.859mm. Total acquisition time was 10 minutes, 12 seconds. 
 
Structural MR Image processing  
The methods used for segmentation and registration of each fast spin echo dataset are described 
in detail elsewhere (Bullmore et al, 1999, Suckling et al, 1996) . Briefly, subject masks were 
generated to identify neural tissue.  Extra-cerebral tissues were removed initially, using an 
automated algorithm.     Manually editing the skull-stripped images was necessary only to 
remove brainstem and cerebellum from the cerebral hemispheres and diencephalon.  The 
probability of each intracerebral voxel belonging to each of four possible tissue classes (grey 
matter, white matter, cerebro spinal fluid [CSF], or dura/vasculature) was estimated with a 
modified fuzzy clustering algorithm (Suckling et al, 1996). This type of segmentation assigns for 
each voxel, a value in the range 0-1 indicating the fraction of the voxel comprised by each tissue 
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type (e.g. a grey matter value of 0.7, means 70% of tissue represented by that voxel is grey 
matter; therefore the value indicates the proportion of the voxel occupied by grey matter).  Total 
grey tissue volume was calculated at this stage of the analysis.    
 
The construction of the sample’s template image is described elsewhere (Dazzan et al, 2004). In 
summary, a template image was constructed using the AFNI (Analysis of Functional 
Neuroimages) program from 6 proton-density images acquired from 6 healthy controls and then 
averaging these images. Tissue distribution maps were registered onto the template by first 
registering each subject’s proton density image using a 9-parameter affine registration, 
minimising between image grey-level difference between images.  This registration aligns all the 
images together, and scales them to the same gross dimensions.  The derived mapping was then 
applied to the corresponding tissue maps.  
 
Ventricular volume 
Additional masks were generated per subject by tracing around the lateral and third ventricles in 
native space, in every slice in which they were visible.  Ventricles were traced by one rater (SJP), 
blind to age, sex, ethnicity and patient/control status.  Within the masked area, CSF volume was 




Between-group regional differences in grey matter volume were estimated by fitting an analysis 
of covariance (ANCOVA) model at each intracerebral voxel in standard space covarying for age 
8 
and total grey matter volume. Permutation testing was used to assess statistical significance, and 
regional relationships were tested at voxel cluster level (Bullmore et al, 1999, Sigmundsson et al, 
2001). Given that structural brain changes are likely to extend over a number of contiguous 
voxels, test statistics incorporating spatial information, such as 3D cluster mass (the sum of 
suprathreshold voxel statistics), are generally more powerful than other possible test statistics 
informed only by single voxel data. We set the statistical threshold for cluster significance in all 
analyses so that the expected number of false positive clusters (p-value times number of tests) 
was <1 false positive.   We examined the association between grey matter cluster size with 
measures for DOI, DAE and total symptoms using Pearson correlation coefficients. Students T 
test calculations were used to analyse between-group differences in ventricle to brain volume 







44 patients received an ICD-10 schizophrenia diagnosis and 29 patients a diagnosis of bipolar 
disorder (n=17) or psychotic depression (n=12). T-tests and Chi Square analyses showed there 
were no significant differences between the ‘Schizophrenia’ and ‘Affective Psychosis’ groups in 
terms of DOI, DAE, total symptom scores and number of compulsory admissions.  The 
percentage of patients who were prescribed atypical antipsychotics was higher among patients 
with schizophrenia than in those with affective psychosis (22 [50%] versus 2 [7%], χ2=16.7, 
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p<.001).  More patients with affective psychosis were prescribed typical antipsychotics (48%) 
than patients with schizophrenia (30%).  This difference did not reach statistical significance.   
(Table 2). 
 
Schizophrenia versus controls 
Patients with schizophrenia had, on average, 2 less years of education (mean 12.4 [sd 2.0] years 
versus 14.1 [sd 2.6] years, t=3.5, df=86, p=.001) and scored significantly lower on the National 
Adult Reading Test (NART), an estimated measure of pre-morbid IQ (Nelson and Willison, 
1991) (93.3 [sd 16.0], versus 106.5 [sd 11.9], t=4.1, df=75, p<.001).  T-tests and Chi Square 
analyses showed there were no significant differences between the schizophrenia patients and 
controls in terms of age, gender, handedness, parental socio-economic status (PSES) and 
ethnicity. (Table 1).  
 
Total tissue and ventricular volumes 
There were no between-group differences in total grey matter or CSF volume. However, patients 
with schizophrenia had significantly larger lateral ventricle VBR (+24.9% volume: t=2.33, 
df=86, p<.03) and larger third ventricle VBR (+63.2% volume: t=3.08, df=86, p<.01) than 
healthy controls.  (Table 3). 
 
Regional proportional grey tissue volume differences  




However, a secondary analysis of the grey matter map using a lowered statistical threshold for 
cluster significance (p-value set at .01), detected 3 excess grey matter areas and 1 grey matter 
deficit area in the patients.  The excess clusters were located in the left and right lenticular 





Symptomology, DOI and DAI 
These clinical factors were not associated with lateral or third ventricle volume (Table 4).  
 
Affective psychosis versus controls 
T-tests and Chi Square analyses showed there were no significant differences between the 
affective patients and controls in terms of age, gender, years of education, NART, handedness, 
PSES and ethnicity.  (Table 1). 
 
Total tissue and ventricular volumes 
There were no between-group differences in total grey matter or CSF volume. Patients with 
affective psychosis had larger third ventricle VBR than controls (+70% volume: t=2.72, df=56, 
p<.01), but there was no significant between-group difference in lateral ventricle volume.   
(Table 3).  
 
Regional proportional tissue volume differences   
11 
Four regional clusters of grey matter deficit were identified in patients with affective psyhcosis 
compared to the controls. These were located: 1) bilaterally within the anterior cingulate gyrus 
(centred Brodmann’s Area (BA) 24), and extending anteriorly to BA31 and BA31 and 
posteriorly to BA23; 2) within the left insula; 3) at the right postcentral gyrus (BA1 and BA2); 4) 
at the left fusiform gyrus (BA37) and extending laterally into the lingual gyrus.  The patients had 
a single grey matter excess cluster located in the left lenticular nucleus. (Table 4; Figure 1).    
 
Symptomology, DOI and DAE 
Longer DAE correlated with increased third ventricle volume (r=.49, p=.007) and increased 
lateral ventricle volume (r=.54, p=.003). Increased third ventricle volume correlated with higher 
total symptom scores (r=.41, p=.03).   The amount of grey matter in the regional deficit and 
excess tissue clusters identified did not correlate with symptomology scores, DOI or DAE. 
(Table 4). 
TABLE 4 HERE 
FIGURE 1 HERE 
 
Schizophrenia versus affective psychosis 
The proportion of males in the schizophrenia group was significantly higher (n=31 [70.4%] 
versus n=11 [38.0%] χ2=7.60 , df=1, p=.006). Patients with schizophrenia had on average, 1.1 
less years of education (mean 12.4 [sd 2.0] years versus 13.5 [sd 2.5] years, t=1.96, df=71, 
p=.056) and scored significantly lower on the National Adult Reading Test (NART) (93.3 [sd 
16.0], versus 102.8 [sd 14.0], t=2.5, df=63, p=.016).  Patients with schizophrenia were on 
average 3.2 years younger than the patients with affective psychosis (25.8 [sd 7.1] years versus 
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29.0 [sd 7.9] years).  This difference in age bordered on statistical significance (t=1.78, df=71, 
p=.079).  T-tests and Chi Square analyses showed there were no significant differences between 
the two patient groups in terms of handedness, parental socio-economic status (PSES) and 
ethnicity. (Table 1).  
 
Total tissue and ventricular volumes 
An ANCOVA (controlling for age and sex) was used compare total tissue and ventricular 
volumes. There were no between-group differences in total grey matter, CSF volume or 
ventricular volumes.  (Table 3). 
 
Regional proportional grey tissue volume differences  
In addition to age and total grey matter volume, sex was also added as a covariate in the analysis 
of regional grey matter differences. One regional cluster of grey matter deficit was identified in 
the affective psychosis group. This was located bilaterally within the anterior cingulate gyrus, 
centred on Brodmann’s Area (BA) 24, and extending anteriorly to BA31 and BA32 and 
posteriorly to BA23. (Table 4).   As there were significant differences in the type of 
antipsychotic taken, an additional analysis adding type of antipsychotic as a covariate (typicals, 
atypicals or none) was performed. When type of antipsychotic was added as a covariate, there 




In contrast with other first-onset MRI investigations, we found relatively few structural 
abnormalities in schizophrenia but identified several regional grey matter deficits in the affective 
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psychoses.    Furthermore, in patients with affective disorders, but not with schizophrenia, we 
found increased ventricular volumes to be associated with higher total symptom ratings and 
longer lifetime use of antipsychotics.   
   
Schizophrenia 
Our finding of increased ventricular volume is consistent with other first-episode schizophrenia 
studies (Fannon et al, 2000b, Cahn et al, 2002).  Evidence of ventricular enlargement in first-
episode patients either never treated, or minimally treated with antipsychotics (Fannon et al, 
2000b) suggests that this abnormality either predates or closely follows psychosis onset and it is 
perhaps of note that in our sample, ventricular abnormalities in schizophrenia were not 
associated with symptomology, DOI or DAE.  Contrary to our prediction that patients with 
schizophrenia would show frontal and temporal grey matter reductions and increased striatal 
grey matter, no grey matter abnormalities were found.   To explore the possibility that this could 
have been due to a lack of statistical power,  we re-ran the grey matter comparison using a lower 
statistical threshold. This analysis identified grey matter differences in two of the predicted 
locations: lenticular nuclei increases (left and right) and reductions in the right parahippocampal 
gyrus (part of the temporal lobe).   Although in this post-hoc analysis the possibility of false-
positive Type 1 errors is increased, the findings may nevertheless indicate the presence of a 
pattern of structural abnormalities similar but less pronounced than that reported elsewhere 




We found enlargement of third ventricle in the affective psychoses, but in contrast to the 
schizophrenia patients, this was correlated with higher total symptom scores and longer DAE.   
The latter may indicate that this brain abnormality is less likely to reflect neurodevelopmental 
pathology than in schizophrenia 
 
The grey matter deficits we found are in line with other studies of affective disorders.  Anterior 
cingulate gyrus (ACG) deficits have been found in bipolar disorder (Sassi et al, 2004) and major 
depression (Bremner et al, 2002) and in people with a genetic risk for bipolar disorder, but not 
for schizophrenia (McDonald et al, 2004).  Findings such as these suggest a role for the ACG in 
the regulation of emotions.  Combined ratings for affective symptoms (depression and mania) in 
the affective psychosis group were as one might expect higher than in the schizophrenia group 
(t=2.8, p=.008), but a post-hoc analysis showed no correlation between severity of affective 
symptoms and the amount of grey matter in the ACG cluster.      
 
Recent findings have shown left fusiform grey matter deficits in patients with mixed psychotic 
disorders, scanned one year after psychosis onset (Pantelis et al, 2003).  The possible role of the 
fusiform gyrus in the psychopathology of psychosis remains unclear but it has been suggested 
that it is implicated in the appraisal and encoding of faces in disorders such as schizophrenia 
(Onitsuka et al, 2003).    In our sample we found no correlation between fusiform grey matter 
volume and symptoms scores, DOI and DAE.     Similarly, no association was found between 
those variables and grey matter volume in the two other deficit regions identified in our affective 
psychotic patients: the post central gyrus and the left insula.  While a recent VBM study (Job et 
al, 2002) observed reduced postcentral gyrus grey matter in schizophrenia, there have been few 
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reports elsewhere in the psychosis literature of structural abnormalities in this region.  On the 
other hand, left insula grey matter deficits have previously been reported in VBM studies of 
affective psychosis (Kubicki et al, 2002), as well as in first-onset schizophrenia (Kasai et al, 
2003b) and schizophrenia of mixed chronicity (Kubicki et al, 2002).    
 
The finding of more grey matter deficits in affective psychosis than in schizophrenia was 
contrary to our predictions and is at variance with other studies of psychosis.  It is unlikely the 
findings can be accounted for by anomalies in image acquisition or processing as such effects 
would not occur systematically in one group only.  One possible confounder is between-patient 
group differences in prescribed antipsychotics; this could provide some explanation for these 
findings as recent research suggests different effects of typical and atypical antipsychotics on 
brain structure (Lieberman et al, 2005; Garver et al, 2005). Indeed, in an earlier analysis of our 
sample (Dazzan et al, 2005) we found that, in comparison to drug-free patients, patients taking 
typicals, but not those taking atypicals had smaller volumes in the lobulus paracentralis; anterior 
cingulate gyrus; superior and medial frontal gyri; superior and middle temporal gyri; insula; and 
precuneus.    It is conceivable that such an effect might explain the greater deficits in the 
affective psychosis group rather than the schizophrenia group as more patients with affective 
psychosis were taking typical antipsychotics (48%) than patients with  schizophrenia (30%) and 
significantly more patients with schizophrenia were taking atypicals (50% versus 7%). A role for 
differences in pharmacological treatment was confirmed by our additional analysis showing that 
when these differences are taken into account, there are no regional differences in brain structure 
between patient groups.   
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Treatment with typical antipsychotics may also be relevant to the increased left lenticular 
nucleus grey matter as these drugs have a strong affinity to sub-cortical D2 dopamine receptors 
and receptor blockade may induce cellular growth and increase blood-flow (Corson et al, 2002).   
Striatal enlargement appears less likely in patients treated only with atypical antipsychotics 
(Corson et al, 1999), which have weaker D2 receptor affinity.   Indeed, in a previous analysis on 
this first-onset sample, we showed that patients treated with atypicals have similar striatal 
volumes to drug-free patients, while subjects taking typicals had significantly larger basal 
ganglia volumes than drug-free patients (Dazzan et al, 2005).  
 
Schizophrenia and affective psychosis 
A direct comparison of the two patients groups (controlling for between-group differences in 
age, sex and total grey matter volume) revealed grey matter of the anterior cingulate gyrus in the 
affective psychosis patients, but no other neuroanatomical differences.     This was consistent 
with the findings of the patient-control comparisons.  The affective psychosis patients were 
prescribed more typical antipsychotics and significantly less atypical antipsychotics than the 
patients with schizophrenia.  When the analysis was repeated controlling for type of 
antipsychotic, no between group differences were found. This suggests that grey matter changes 
may be associated with variations in the type antipsychotic taken and is consistent with our 
previous finding of typicals being associated with grey matter reductions in the anterior cingulate 
gyrus (Dazzan et al, 2005). 
 
The finding of regional deficits in the patients with affective psychosis was of interest and 
indicates that some morphological changes take place in those patients close to illness onset or at 
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prodromal or even premorbid stage. We found significant, but fewer neuroanatomical 
abnormalities in schizophrenia. The absence of more widespread differences in these patients 
might be accounted for by the epidemiological basis of our study, in which both patients and 
controls were recruited from the same catchment area. Using an epidemiologically based sample 
avoids the potential bias of recruiting subjects according to factors such as illness severity and 
family history. Many reports on first-episode schizophrenia patients come from university 
clinics, referral centres and in-patient samples which attract subjects not necessarily 
representative of first-episode schizophrenia in general (Job et al, 2002, Pantelis et al, 2003) and 
it is possible that our findings do not reflect the findings reported in patients with more severe 
illnesses. The use of an epidemiological sample may also explain in part, the findings in the 
affective psychosis sample.  The recruitment of those patients was not based on referrals from 
bipolar and other affective clinics and may have resulted in a more psychotic affective sample 
than that seen in earlier MRI studies of affective disorders.  
CLINICAL IMPLICATIONS  
• Ventricular enlargement was associated with symptomology and duration of illness in 
affective psychosis but not in schizophrenia.  This may indicate that this particular brain 
abnormality is more likely to reflect a neurodevelopmental pathology in schizophrenia 
compared to the affective psychoses.   
• As in schizophrenia, patients with affective psychotic disorders show subtle neuroanatomical 
changes early in their illness, 
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• Differential treatment with typical and atypical antipsychotics may contribute to brain 
structural differences seen in patients with schizophrenia and affective psychosis. 
LIMITATIONS 
• The finding of grey matter abnormalities in the schizophrenia patients at a lower statistical 
threshold suggests that more grey matter changes in this group may have been identified in a 
larger sample. 
• Because there may be longitudinal MRI changes following the first episode, a different 
pattern of group differences may be evident when patients are studied later in the illness. 
• Our appraisal of the relationship between antipsychotic medication, grey matter change and 
diagnosis was limited by the fact that patients could not be selected into the study of their 
basis of drug prescription (or drug free) status. 
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 mean (sd) mean (sd) t     p mean (sd) mean (sd) t        p t        p 
Age 
 
 25.8 (7.1)   25.8 (7.1) .01       .99 29.0 (7.9) 28.8 (7.3) .09     .93 1.78     .079 
Years of education 
 
12.4 (2.0)   14.1 (2.6) 3.5        .001 13.5 (2.5) 14.0 (2.5) .74      .46 1.96     .056 
Pre-morbid IQ (NART) a 93.3 (16.0) 106.5 (11.9) 4.1,     <.001 102.8 (14.0) 106.7 (10.8) 1.16     .25 2.50     .016 
 n  n   χ2     p n  n   χ2   p χ2       p 
Sex: male/female 31/13 31/13   0    1.0 11/18 11/18 0       1.0 7.61     .006 
Parental SES:  managerial/ 
intermediate/working 
14/12/18 13/18/13 2.0     .38 11/5/13 9/13/7  5.6      .06 1.0       .60 
Ethnicity: White British/         
Not white British 
16/28 18/26  .66     .83 10/19 13/16 .65       .42 .03       .87 
Handedness b 
Right /Left 
6/38 4/38  .45     .50 1/28 4/28 2.1      .15 2.3       .32 
a NART scores not available for 6 patients with schizophrenia, 2 patients with ‘affective psychosis’ and 7 controls. 




Table 2 : Clinical characteristics of the patient sample 
 Schizophrenia  
(n=44) 
Affective 
psychosis  (n=29) 
Analysis 
 
 mean (sd) [median] mean (sd) [median] t (df=71)  
 p 
Duration of illness (weeks) 67.1 (124.9) [22.4] 48.7 (109.9) [26.7]   .52*  .60 
Total symptom rating 30.1 (20.5) 32.5 (13.3)   .43  .67 
Affective symptoms  6.8 (8.6) 12.7 (8.4) 2.75  .008 
Duration of antipsychotic 
treatment (wks) 
 8.5 (8.2)   6.5 (9.4)   .98  .33 
 n (%) n (%) χ2  
Type of antipsychotic 
 Typical only 
 Atypical only 
        Mixed   




  2   (5) 
  7 (16) 
 
14 (48) 
  2 (7) 
  3 (10) 
10 (35) 
 
  .04 
16.7 
  0.20 
  0.53 
 
 .85 
     <.001 
 .66 
 .47 
Compulsory  admission 26 (60) 15 (52)     .54  .46 







Table 3: Mean total tissue, total CSF and ventricular volumes (ml) in patients and 
normal controls 
 Grey matter Total CSF Lat. ventricle* Third ventricle a  
Schizophrenia (n=44) 581.2 (64.4) 156.9 (32.4) 18.6 (10.2) .31 (.21) 
Matched controls (n=44) 595.8 (57.0) 160.2 (28.8) 15.3 (6.7) .19 (.15) 
% vol. difference -2.5 -2.1 +17.7 +63.2 
Analysis: t=1.24, p=.26 t=.51, p=.61 t=2.33, p<.03 t=3.08, p<.01 
     
Affect. Psychosis (n=29) 561.3 (52.3) 147.8 (30.6) 15.7 (6.7) .34 (.26) 
Matched controls (n=29) 573.5 (52.9) 148.5 (27.2) 13.31 (6.3) .20 (.14) 
% vol. difference -2.1 -.5 +18.0 +70.0 
Analysis t=.88, p=.38 t=.09, p=.93 t=1.70, p=.09 t=2.72, p<.01 
     
Schizophrenia vs Affect. 
Psychosis  
    
% vol. difference: +3.5 +6.2 +18.5 -9.7 
Analysis f=.01, p=.09 f=.13, p=.72 f=1.46, p=.23 f=.84, p=.36 
a Volume (ml) shown, analysis calculated according to ratio of ventricle to total grey matter volume 
b ANCOVA (controlling for age and sex) performed in schizophrenia vs affective psychosis analysis 
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Table 4:  a) Regional differences in grey matter: patients versus normal controls and schizophrenia versus affective psychosis 
  b) Correlation of clinical factors (DOI, total symptoms scores [TSS] and duration of antipsychotic  exposure [DAE] with grey 
  matter volume and ventricle to whole brain ratios 




cluster centre  
(x, y, z) 
Correlations  r 
Schizophrenic patients (n=44) versus matched controls (n=44)   DOI TSS DAE 
Lateral ventricle to whole brain ratio - -  .12  .02 .01 
Third ventricle to whole brain ratio - -  .16  .28 .11 
Affective psychosis (n=29) versus matched  controls (n=29)      
Grey matter deficits:      
Anterior cingulate gyrus BA 24, extending bilaterally to BA 32, 31, 23 728 1, -10, 30 .10 -.05 -.10 
Insula cortex (left) 269 -41, 0, -2 .20 .10 .24 
Post central gyrus (right) BA 1,2 230 47, -21, 37 .38 -.10 -.35 
Fusiform gyrus BA 37, 19 (left), extending laterally to lingual gyrus 158 -25, -52, -11 -.10 -.01 -.20 
Other areas: 
Lenticular nucleus (left): grey matter excess 474 -28, -6, 6 -.26 .29 -.15 
Lateral ventricle to whole brain ratio - - .02 .26 .54b 
Third ventricle to whole brain ratio - - -.21 .41 a .49b 
Schizophrenic patients (n=44) versus affective psychosis (n=29)      
Grey matter deficit (in affective psychosis):      
Anterior cingulate gyrus BA 24, extending bilaterally to BA 32, 31, 23 720 1,  -2,  36 .17 -.06 .02 
a p<.05,   b p<.01,   BA = Brodmann area 
 
 

